BIO Offers Advice for FDA

August 2011
Pharmaceutical Representative;Aug2011, Vol. 41 Issue 8, p11
The article reports on the proposals of the Biotechnology Industry Organization (BIO) on improving the regulatory operations of the U.S. Food and Drug Administration (FDA).


Related Articles

  • Industry, FDA agree on $100 million in fees.  // Medical Marketing & Media;May2002, Vol. 37 Issue 5, p35 

    Reports on the agreement between the U.S. Food and Drug Administration with the Biotechnology Industry Organization and the Pharmaceutical Research and Manufacturers of America on the renewal of the Prescription Drug User Fee Act. Increase in user fees in 2003; Use of the funds to invigorate...

  • Congressional reform of FDA gets more suggestions from industry.  // Drug Topics;3/20/95, Vol. 139 Issue 6, p74 

    Reports on the assistance being given by three former Food and Drug Administration (FDA) commissioners and an former congressman to the pharmaceutical industry in devising an FDA reform plan to present to Congress. Biotechnology Industry Organization's announcement of its preliminary views on...

  • Consumers And Cloning. Rutherford, Burt // BEEF;Jul2007, Vol. 43 Issue 11, p30 

    The article discusses the reaction of consumers to cattle cloning as part of technological advancement in the U.S. As defined by Washington, D. C.-based Biotechnology Industry Organization managing director Barbara Glenn, cloning is an assisted reproductive technology designed to make a twin of...

  • FDA Approves 16 New Biotech-Based Medicines.  // Chemical Market Reporter;2/18/2002, Vol. 261 Issue 7, p9 

    Reports on the approval of several biotechnology-based medicines and vaccines in 2001 by the U.S. Food and Drug Administration (FDA). Information on the uses of the drugs and vaccines according to the Biotechnology Industry Organization; Significance of the approval by the FDA; Factor that...

  • FDA Summarizes Near-Term Goals as Conference Wraps. Morrison, Trista // BioWorld Today;6/23/2008, Vol. 19 Issue 121, p1 

    The article reports on the highlights of the 2008 Biotechnology Industry Organization meeting that was held in San Diego, California. The event recorded slightly more than 20,000 registrants. One area in the meeting was where Deborah Henderson, director of the office of executive programs at the...

  • Exclusivity Issue Needlessly Thwarting Biogenerics Debate. Thiel, Karl // BioWorld Today;7/1/2009, Vol. 20 Issue 125, p1 

    The article reports on the issues surrounding the exclusivity of the biogenerics legislation in the U.S. It notes the contention of the Biotechnology Industry Organization (BIO) on the number of years of data exclusivity an innovator product would enjoy before a follow-on products could be...

  • Back-to-Basics with PDUFA V. Radcliffe, Sara // Pharmaceutical Technology;Jun2012, Vol. 36 Issue 6, p12 

    The author reflects on the patient-centric approach to the Prescription Drug User Fee Act (PDUFA V) called by the Biotechnology Industry Organization (BIO). The author says that a set of PDUFA enhancement was agreed by the biotechnology, pharmaceutical industries, and the U.S. Food and Drug...

  • Advances in Drug development & Approvals Landscape, and Industry Partnerships. Pestonjamasp, Vasu // Journal of Commercial Biotechnology;Oct2014, Vol. 20 Issue 4, p54 

    The article presents brief information on the Biotechnology Industry Organization's 2014 Annual Convention held at the San Diego Convention Center in California on June 23-26, 2014. It mentions that event was attended by several biotech industry leaders that included 2,500 chief executive...

  • GPhA, BIO Welcome FDA Guidance on Pathway for Biosimilars.  // Chain Drug Review;2/27/2012, Vol. 34 Issue 4, p42 

    The article reports that the Generic Pharmaceutical Association and Biotechnology Industry Organization have approved the U.S. Food and Drug Administration' guidance regarding the similarity of generic drugs with biological products.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics